chr3-193263133-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_020386.5(PLAAT1):c.303G>A(p.Arg101Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00586 in 1,614,108 control chromosomes in the GnomAD database, including 299 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.025 ( 147 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 152 hom. )
Consequence
PLAAT1
NM_020386.5 synonymous
NM_020386.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.796
Genes affected
PLAAT1 (HGNC:14922): (phospholipase A and acyltransferase 1) Enables acyltransferase activity, transferring groups other than amino-acyl groups and phospholipase activity. Involved in N-acylphosphatidylethanolamine metabolic process and phosphatidylcholine metabolic process. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 3-193263133-G-A is Benign according to our data. Variant chr3-193263133-G-A is described in ClinVar as [Benign]. Clinvar id is 786508.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.796 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0789 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLAAT1 | NM_020386.5 | c.303G>A | p.Arg101Arg | synonymous_variant | 3/4 | ENST00000264735.4 | NP_065119.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLAAT1 | ENST00000264735.4 | c.303G>A | p.Arg101Arg | synonymous_variant | 3/4 | 1 | NM_020386.5 | ENSP00000264735.4 | ||
PLAAT1 | ENST00000650797.1 | c.618G>A | p.Arg206Arg | synonymous_variant | 3/4 | ENSP00000498228.1 | ||||
PLAAT1 | ENST00000416012.1 | n.132G>A | non_coding_transcript_exon_variant | 1/3 | 5 | ENSP00000414431.1 |
Frequencies
GnomAD3 genomes AF: 0.0253 AC: 3848AN: 152126Hom.: 147 Cov.: 32
GnomAD3 genomes
AF:
AC:
3848
AN:
152126
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00827 AC: 2079AN: 251444Hom.: 62 AF XY: 0.00687 AC XY: 933AN XY: 135894
GnomAD3 exomes
AF:
AC:
2079
AN:
251444
Hom.:
AF XY:
AC XY:
933
AN XY:
135894
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00383 AC: 5604AN: 1461864Hom.: 152 Cov.: 32 AF XY: 0.00352 AC XY: 2559AN XY: 727232
GnomAD4 exome
AF:
AC:
5604
AN:
1461864
Hom.:
Cov.:
32
AF XY:
AC XY:
2559
AN XY:
727232
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0253 AC: 3852AN: 152244Hom.: 147 Cov.: 32 AF XY: 0.0251 AC XY: 1868AN XY: 74440
GnomAD4 genome
AF:
AC:
3852
AN:
152244
Hom.:
Cov.:
32
AF XY:
AC XY:
1868
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
23
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 04, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at